KONINKLIJKE PHILIPS NV (PHIA.AS) Fundamental Analysis & Valuation

AMS:PHIA • NL0000009538

25.305 EUR
+0.48 (+1.91%)
Last: Mar 10, 2026, 03:57 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This PHIA.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to PHIA. PHIA was compared to 65 industry peers in the Health Care Equipment & Supplies industry. PHIA may be in some trouble as it scores bad on both profitability and health. PHIA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. PHIA.AS Profitability Analysis

1.1 Basic Checks

  • PHIA had positive earnings in the past year.
  • In the past year PHIA had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
  • Of the past 5 years PHIA 4 years had a positive operating cash flow.
PHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFPHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 3.32%, PHIA is in line with its industry, outperforming 47.69% of the companies in the same industry.
  • With a Return On Equity value of 8.17%, PHIA perfoms like the industry average, outperforming 56.92% of the companies in the same industry.
  • PHIA's Return On Invested Capital of 5.50% is in line compared to the rest of the industry. PHIA outperforms 49.23% of its industry peers.
  • PHIA had an Average Return On Invested Capital over the past 3 years of 3.48%. This is significantly below the industry average of 10.72%.
  • The last Return On Invested Capital (5.50%) for PHIA is above the 3 year average (3.48%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROIC 5.5%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
PHIA.AS Yearly ROA, ROE, ROICPHIA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • PHIA's Profit Margin of 5.02% is in line compared to the rest of the industry. PHIA outperforms 46.15% of its industry peers.
  • PHIA's Profit Margin has declined in the last couple of years.
  • The Operating Margin of PHIA (7.98%) is comparable to the rest of the industry.
  • PHIA's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 45.18%, PHIA is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
  • PHIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
PHIA.AS Yearly Profit, Operating, Gross MarginsPHIA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. PHIA.AS Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHIA is destroying value.
  • PHIA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PHIA has been increased compared to 5 years ago.
  • Compared to 1 year ago, PHIA has a worse debt to assets ratio.
PHIA.AS Yearly Shares OutstandingPHIA.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M
PHIA.AS Yearly Total Debt VS Total AssetsPHIA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.03 indicates that PHIA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • PHIA has a Altman-Z score of 2.03. This is in the lower half of the industry: PHIA underperforms 60.00% of its industry peers.
  • The Debt to FCF ratio of PHIA is 16.37, which is on the high side as it means it would take PHIA, 16.37 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 16.37, PHIA is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 0.63 indicates that PHIA is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.63, PHIA is doing worse than 64.62% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Altman-Z 2.03
ROIC/WACC0.84
WACC6.56%
PHIA.AS Yearly LT Debt VS Equity VS FCFPHIA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

2.3 Liquidity

  • PHIA has a Current Ratio of 1.32. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
  • PHIA has a Current ratio of 1.32. This is comparable to the rest of the industry: PHIA outperforms 41.54% of its industry peers.
  • A Quick Ratio of 0.94 indicates that PHIA may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.94, PHIA is doing worse than 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.94
PHIA.AS Yearly Current Assets VS Current LiabilitesPHIA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. PHIA.AS Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 6.11% over the past year.
  • Measured over the past years, PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.62% on average per year.
  • Looking at the last year, PHIA shows a decrease in Revenue. The Revenue has decreased by -1.03% in the last year.
  • PHIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.59% yearly.
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%

3.2 Future

  • Based on estimates for the next years, PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.24% on average per year.
  • The Revenue is expected to grow by 3.78% on average over the next years.
EPS Next Y4.04%
EPS Next 2Y8.35%
EPS Next 3Y10.36%
EPS Next 5Y10.24%
Revenue Next Year1.29%
Revenue Next 2Y2.83%
Revenue Next 3Y3.44%
Revenue Next 5Y3.78%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHIA.AS Yearly Revenue VS EstimatesPHIA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHIA.AS Yearly EPS VS EstimatesPHIA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

More info and screens

Find the best growth stocksShow best growing peers

4

4. PHIA.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.21, PHIA is valued on the expensive side.
  • Based on the Price/Earnings ratio, PHIA is valued cheaper than 87.69% of the companies in the same industry.
  • PHIA is valuated rather cheaply when we compare the Price/Earnings ratio to 26.45, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 16.55, the valuation of PHIA can be described as correct.
  • 69.23% of the companies in the same industry are more expensive than PHIA, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of PHIA to the average of the S&P500 Index (24.65), we can say PHIA is valued slightly cheaper.
Industry RankSector Rank
PE 17.21
Fwd PE 16.55
PHIA.AS Price Earnings VS Forward Price EarningsPHIA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • PHIA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PHIA is cheaper than 73.85% of the companies in the same industry.
  • The rest of the industry has a similar Price/Free Cash Flow ratio as PHIA.
Industry RankSector Rank
P/FCF 49.33
EV/EBITDA 11.46
PHIA.AS Per share dataPHIA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.26
PEG (5Y)N/A
EPS Next 2Y8.35%
EPS Next 3Y10.36%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PHIA.AS Dividend Analysis

5.1 Amount

  • No dividends for PHIA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PHIA.AS Fundamentals: All Metrics, Ratios and Statistics

KONINKLIJKE PHILIPS NV

AMS:PHIA (3/10/2026, 3:57:11 PM)

25.305

+0.48 (+1.91%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)05-06
Inst Owners47.46%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap24.37B
Revenue(TTM)17.84B
Net Income(TTM)895.00M
Analysts75.33
Price Target29.32 (15.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.35
Dividend Growth(5Y)216.55%
DP36.65%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.02%
Min EPS beat(2)3.95%
Max EPS beat(2)14.1%
EPS beat(4)4
Avg EPS beat(4)17.83%
Min EPS beat(4)3.95%
Max EPS beat(4)31.04%
EPS beat(8)4
Avg EPS beat(8)2.84%
EPS beat(12)6
Avg EPS beat(12)6.47%
EPS beat(16)7
Avg EPS beat(16)6.93%
Revenue beat(2)0
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)-0.86%
Revenue beat(4)0
Avg Revenue beat(4)-1.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)-0.86%
Revenue beat(8)0
Avg Revenue beat(8)-2.61%
Revenue beat(12)1
Avg Revenue beat(12)-2.36%
Revenue beat(16)2
Avg Revenue beat(16)-1.72%
PT rev (1m)7.51%
PT rev (3m)6.07%
EPS NQ rev (1m)-20.3%
EPS NQ rev (3m)-14.31%
EPS NY rev (1m)0.51%
EPS NY rev (3m)-0.9%
Revenue NQ rev (1m)2.87%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-2.05%
Valuation
Industry RankSector Rank
PE 17.21
Fwd PE 16.55
P/S 1.37
P/FCF 49.33
P/OCF 20.97
P/B 2.22
P/tB N/A
EV/EBITDA 11.46
EPS(TTM)1.47
EY5.81%
EPS(NY)1.53
Fwd EY6.04%
FCF(TTM)0.51
FCFY2.03%
OCF(TTM)1.21
OCFY4.77%
SpS18.52
BVpS11.38
TBVpS-0.92
PEG (NY)4.26
PEG (5Y)N/A
Graham Number19.4
Profitability
Industry RankSector Rank
ROA 3.32%
ROE 8.17%
ROCE 7.33%
ROIC 5.5%
ROICexc 6.42%
ROICexgc 22.25%
OM 7.98%
PM (TTM) 5.02%
GM 45.18%
FCFM 2.77%
ROA(3y)-0.23%
ROA(5y)0.96%
ROE(3y)-0.52%
ROE(5y)1.86%
ROIC(3y)3.48%
ROIC(5y)N/A
ROICexc(3y)3.99%
ROICexc(5y)N/A
ROICexgc(3y)13.73%
ROICexgc(5y)N/A
ROCE(3y)4.66%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1.19%
ROICexc growth 3YN/A
ROICexc growth 5Y-4.56%
OM growth 3YN/A
OM growth 5Y-5.27%
PM growth 3YN/A
PM growth 5Y-6.05%
GM growth 3Y3.66%
GM growth 5Y-0.43%
F-Score7
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.37
Debt/EBITDA 2.72
Cap/Depr 59.38%
Cap/Sales 3.75%
Interest Coverage 5.63
Cash Conversion 45.59%
Profit Quality 55.2%
Current Ratio 1.32
Quick Ratio 0.94
Altman-Z 2.03
F-Score7
WACC6.56%
ROIC/WACC0.84
Cap/Depr(3y)53.03%
Cap/Depr(5y)53.41%
Cap/Sales(3y)3.68%
Cap/Sales(5y)4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.11%
EPS 3Y15.66%
EPS 5Y-6.62%
EPS Q2Q%-1.96%
EPS Next Y4.04%
EPS Next 2Y8.35%
EPS Next 3Y10.36%
EPS Next 5Y10.24%
Revenue 1Y (TTM)-1.03%
Revenue growth 3Y0.01%
Revenue growth 5Y0.59%
Sales Q2Q%1.05%
Revenue Next Year1.29%
Revenue Next 2Y2.83%
Revenue Next 3Y3.44%
Revenue Next 5Y3.78%
EBIT growth 1Y15922.2%
EBIT growth 3YN/A
EBIT growth 5Y-4.71%
EBIT Next Year68.67%
EBIT Next 3Y26.47%
EBIT Next 5Y17.86%
FCF growth 1Y-43.86%
FCF growth 3YN/A
FCF growth 5Y-22.31%
OCF growth 1Y-25.32%
OCF growth 3YN/A
OCF growth 5Y-15.14%

KONINKLIJKE PHILIPS NV / PHIA.AS FAQ

Can you provide the ChartMill fundamental rating for KONINKLIJKE PHILIPS NV?

ChartMill assigns a fundamental rating of 3 / 10 to PHIA.AS.


What is the valuation status of KONINKLIJKE PHILIPS NV (PHIA.AS) stock?

ChartMill assigns a valuation rating of 4 / 10 to KONINKLIJKE PHILIPS NV (PHIA.AS). This can be considered as Fairly Valued.


Can you provide the profitability details for KONINKLIJKE PHILIPS NV?

KONINKLIJKE PHILIPS NV (PHIA.AS) has a profitability rating of 3 / 10.


How financially healthy is KONINKLIJKE PHILIPS NV?

The financial health rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 1 / 10.


Can you provide the dividend sustainability for PHIA stock?

The dividend rating of KONINKLIJKE PHILIPS NV (PHIA.AS) is 0 / 10 and the dividend payout ratio is 36.65%.